EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSSPAG00000016455
Gene Symbol: CACNA1S
3 Cross references
191 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSPAG00000013597
Gene Symbol: CNR1
3 Cross references
150 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSSPAG00000020477
Gene Symbol: CNR2
3 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSSPAG00000018001
Gene Symbol: CA12
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSPAG00000010349
Gene Symbol: LOC103362297
3 Cross references
79 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSPAG00000018081
Gene Symbol: LOC103363689
3 Cross references
212 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSSPAG00000007355
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSSPAG00000004311
Gene Symbol: CA6
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSSPAG00000017659
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSSPAG00000022549
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSSPAG00000019865
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I Isoform Epsilon-Like

Ensembl ID : ENSSPAG00000004530
Gene Symbol: LOC103368406
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).